On the other hand, although CD133 has been listed as a potential marker for CSCs in lung cancer cells, its reported level in A549 cells in most cases was very low, i.e., it did not exceed 2% [36,44,45,46,47] (which was comparable with our results). This evidence concerns the gene PROM1 and lung carcinoma.